Abstract
Vitiligo is an acquired idiopathic hypomelanotic disorder characterized by circumscribed depigmented macules. There is frequently a family history of the condition or of autoimmune endocrine disease. Vitiligo can lead to social embarrassment, psychological disturbance, and cosmetic disability.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Howitz J, Brodthagen H, Schwartz M et al. Prevalence of vitiligo. Arch Dermatol. 1977; 113: 47–52.
Das SK, Majumder PP, Chakraborty R et al. Studies on vitiligo. I: Epidemiological profile in Calcutta, India. Genet Epidemiol. 1985;2:71–78.
Meollmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner AB. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol. 1982;79:321–330.
Le Poole IC, van den Wijngaard RMJGJ, Westerhof W et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol. 1993;100:816–822.
Bleehen SS. Vitiligo. In: Klaus SN, ed. Pigment Cell, Vol 5. Basel: Karger AG; 1979:54.
Ortonne JP, Mosher DB, Fitzpatrick TB. Vitiligo and other hypomelanosis of hair and skin. New York: Plenum Press; 1983:257–258.
Butterworth T, Stream LP. Vitiligo. Baltimore: Williams and Wilkins; 1962:4–6.
Majumder PP, Das DK, Li CC. A genetic model for vitiligo. Am J Hum Genet. 1988;43:119–125.
Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol. 1993;129:994–998.
Ando I, Chi HI, Nakagawa H, Otsuka F. Differences in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol. 1993; 129: 408–410.
Orrecchia GL, Perfetti L, Malagoli P et al. Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in Northern Italian patients. Dermatology. 1992;185:123–127.
Venkataram MN, White AG, Lenny WA et al. HLA antigens in Omani patients with vitiligo. Clin Exp Dermatol. 1995;20:35–37.
Schallreuter KU, Levenig C, Kuhnl P et al. Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from Northern Germany. Dermatology. 1993;187:186–192.
Venneker GT, Westerhof W, de Vries IJ et al. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo. J Invest Dermatol. 1992;99:853–858.
Kahl LE, Atkinson JP. Autoimmune aspects of complement deficiency. Clin Aspects Autoimmun. 1988;5:8–20.
Cunliffe WJ, Hall DJ, Newell DJ et al. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol. 1968;80:135–139.
Parrish JA, Fitzpatrick TB, Shea C et al. Photochemotherapy of vitiligo. Arch Dermatol. 1976;112:1531–1534.
Dunlop D. Eighty-six cases of Addison’s disease. Br Med J. 1963;ii:887–891.
Tosti A, Bardazzi F, Tosti G et al. Audiologic abnormalities in cases of vitiligo. J Am Acad Dermatol. 1987;17:230–233.
Lerner AB, Halaban R, Klaus SN et al. Transplantation of human melanocytes. J Invest Dermatol. 1987;89:219–224.
Macaron C, Winter RJ, Traisman HS et al. Vitiligo and juvenile diabetes mellitus. Arch Dermatol. 1977;113:1515–1517.
Hegedus L, Heidenheim M, Gervil M et al. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol. 1994;74:120–123.
Schallreuter KU, Lemke R, Brandt O et al. Vitiligo and other diseases: coexistence or true association? Dermatology. 1994;188:269–275.
Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune syndromes. Medicine (Baltimore). 1981;60:355–362.
Ahonen P, Koskimies S, Lokki ML et al. The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab. 1988;66:1151–1157.
Tsokos GC, Gorden P, Antonovych T et al. Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors. Ann Intern Med. 1985;102:176–181.
Lerner AB. On the etiology of vitiligo and gray hair. Am J Med. 1971;51:141–147.
Nordlund JJ, Todes-Taylor N, Albert DM et al. The presence of vitiligo and poliosis in patients with uveitis. J Am Acad Dermatol. 1981;4:528–536.
Cowan CL, Haider RM, Grimes PE, Chakrabarti SG, Kenney JA. Ocular disturbances in vitiligo. J Am Acad Dermatol. 1986;15:17–24.
Barnes L. Vitiligo and the Vogt-Koyanagi-Harada syndrome. Dermatol Clin. 1988;6:229–239.
Frenk E. Depigmentation vitiligineuses chez des patients atteints de melanomes malins. Dermatologica. 1969;1139:84–91.
Veharaa M, Mayauchi H, Tanaka S. Diminished contact sensitivity response in vitiliginous skin. Arch Dermatol. 1984;120:195–198.
Morelli JG. The cause and treatment of vitiligo. Curr Opin Dermatol. 1995;1:105–108.
Ortonne JP, Bose SK. Vitiligo: where do we stand? Pigment Cell Res. 1994;6:61–72.
Lerner AB. Vitiligo. J Invest Dermatol. 1959;32:285–310.
Al’Abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol. 1994;131:160–165.
AlAbadie MSK, Warren MA, Bleehen SS, Gawkrodger DJ. Morphologic observations on the dermal nerves in vitiligo: an ultrastructural study. Int J Dermatol. 1995;34:837–840.
Mozzanica N, Villa ML, Foppa S et al. Plasma a-melanocyte-stimulating hormone,-endorphin, met-enkephalin and natural killer cell activity in vitiligo. J Am Acad Dermatol. 1992;26:693–700.
Bleehen SS, Pathak MA, Hori Y et al. Depigmentation of skin with 4-isopropylcatechol mercaptoamines, and other compounds. J Invest Dermatol. 1968;50:103–117.
Schallreuter KU, Wood JM, Ziegler I et al. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta. 1994; 1226:181–192.
Le Poole C, van der Wijngaard R, Smit NPM et al. Catechol-o-methyltransferase in vitiligo. Arch Dermatol Res. 1994;286:81–86.
Schallreuter KU, Wood JM, Pittelkow MR et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science. 1994;2631:21444–21446.
Schallreuter KU, Wood JM, Berger I. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol. 1991;97:1081–1085.
Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology. 1995;190:223–229.
Naughton GK, Eisenger M, Bystryn JC. Antibodies to normal melanocytes in vitiligo. J Exp Med. 1983;158:246–251.
Bystryn JC. Serum antibodies in vitiligo patients. Clin Dermatol. 1989;2:136–145.
Harning R, Cui J, Bystryn JC. Relationship between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol. 1991;97:1078–1080.
Cui J, Arita Y, Bystryn JC. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol. 1993;100:812–815.
Yu CL, Kao CH, Yu HS. Co-existence and relationship of antikeratinocyte and antimelano-cyte antibodies in patients with non-segmental-type vitiligo. J Invest Dermatol. 1993; 100: 823–828.
Abdel Nasser MB, Gollnick H, Orfanos CE. Evidence of primary involvement of keratino-cytes in vitiligo. Arch Dermatol Res. 1991;283:47–48.
Gilhar A, Zelickson B, Ulman Y, Etzioni A. In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo. J Invest Dermatol. 1995;105:683–686.
Song YH, Connor E, Li Y et al. The role of tyrosinase in autoimmune vitiligo. Lancet. 1994; 344:1049–1052.
Grimes PE, Ghoneum M, Stockton T, Payne C, Kelly P, Alfred L. T-cell profiles in vitiligo. J Am Acad Dermatol. 1986;14:196–201.
Abdel Nasser MB, Kruger S, Krasagakis K et al. Evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. J Invest Dermatol. 1991;96:1024.
Gross A, Tapis FJ, Mosea W et al. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromiscum perstans and vitiligo. Histol Histopathol. 1987;2: 277–287.
Durham-Pierre DG, Walters CS, Halder RM et al. Natural killer cell and lymphokine-associated killer cell activity against melanocytes in vitiligo. J Am Acad Dermatol. 1995;33: 26–30.
Gilhar A, Aizen E, Ohana N, Etzioni A. Vitiliginous vs pigmented skin response to intradermal administration of interferon gamma. Arch Dermatol. 1993;129:600–604.
El Magrabi IAS. Clinical, histological and immunopathological studies on vitiligo. PhD thesis, University of Sheffield, 1990.
Norris DA. Cytokine modulation of adhesion molecules in the regulation of immunocyto-toxicity of epidermal targets. J Invest Dermatol. 1990;95:111S–120S.
Al Badri AMT, Foulis AK, Todd PM et al. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J Pathol. 1993;169:203–206.
Campbell IL, Harrison LC. Molecular pathology of type I diabetes. Mol Biol Med. 1990;7: 299–309.
Zheng RQH, Abney ER, Grubeck-Loebenstein B et al. Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves’ and Hashimoto’s diseases. J Autoimmun. 1990;3:727–736.
Nakazawa K, Bonnard M, Damour O, Collombel C. Functional role of E-cadherin in melanocyte-keratinocyte adhesion in vitro. Melanoma Res. 1995;5(2):40.
Morelli JG, Kincannon J, Yohn JJ et al. Leukotriene C4 and TGF-α are stimulators of human melanocyte migration in vivo. J Invest Dermatol. 1992;98:290–295.
Morelli JG, Yohn JJ, Zekman T, Norris DA. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol. 1993;101:605–608.
Hedley SJ, Gawkrodger DJ, Weetman AP, MacNeil S. Extracellular matrix proteins stimulate melanocyte tyrosinase. Melanoma Res. 1995;5(2):38–39.
Lerner AB, Shiohara T, Boissy RE et al. A mouse model for vitiligo. J Invest Dermatol. 1986; 87:299–304.
Gilhar A, Pillar T, Eidelman S, Etzioni A. Vitiligo and idiopathic guttate hypomelanosis. Repigmentation of skin following engraftment onto nude mice. Arch Dermatol. 1989;125: 1363–1366.
Oliver EA, Schwartz L, Warren LH. Occupational leukoderma. Arch Dermatol Syphilol. 1940;101:163–169.
Malten KE, Seutter E, Hara I, Nakajima T. Occupational vitiligo due to paratertiary butyl phenol and homologues. Trans St John’s Dermatol Soc. 1971;57:115–131.
Gellin GA, Possick PA, Perone VB. Depigmentation from 4-tertiary butyl catechol. J Invest Dermatol. 1970;55:190–197.
Nordlund JJ, Lerner AB. Vitiligo: is it important? Arch Dermatol. 1982;118:5–8.
Barona MI, Arrunategui A, Falabella R, Alzate A. An epidemiological case-control study in a population with vitiligo. J Am Acad Dermatol. 1995;33:621–625.
Taylor JS, Maibach HI, Fisher AA, Bergfeld WF. Contact leukoderma associated with the use of hair colors. Cutis. 1993;52:273–280.
Grimes PE. Vitiligo: an overview of therapeutic approaches. Dermatol Clin. 1993;11:325–338.
Wildfang IL, Jacobsen FK, Thestrup-Pedersen K. PUVA treatment of vitiligo: a retrospective study of 59 patients. Acta Derm Venereol. 1992;72:305–306.
Anstey A, Hawk JLM. PUVA treatment of vitiligo. Br J Dermatol. 1994; 131(44): 18.
Orrecchia G, Perfetti L. Photochemotherapyy with topical khellin and sunlight in vitiligo. Dermatology. 1992;184:120–123.
Passi S, Picardo M, De Luca M et al. Treatment of vitiligo with an antioxidant pool. Melanoma Res. 1995;5(2):25.
Zachariae H, Zachariae C, Deleuran B, Kristensen P. Autotransplantation in vitiligo: treatment with epidermal grafts and cultured melanocytes. Acta Derm Venereol. 1993;73: 46–48.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gawkrodger, D.J. (1998). Vitiligo. In: Weetman, A.P. (eds) Endocrine Autoimmunity and Associated Conditions. Immunology and Medicine Series, vol 27. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5044-6_13
Download citation
DOI: https://doi.org/10.1007/978-94-011-5044-6_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6118-6
Online ISBN: 978-94-011-5044-6
eBook Packages: Springer Book Archive